Risk factors associated with metastatic site failure in patients with high-risk neuroblastoma

Risk factors associated with metastatic site failure in patients with high-risk neuroblastoma

Purpose: This retrospective study sought to identify predictors of metastatic site failure (MSF) at new and/or original (present at diagnosis) sites in high-risk neuroblastoma patients. Methods and materials: Seventy-six high-risk neuroblastoma patients treated on four institutional prospective tria...

Full description

Bibliographic Details
Main Authors:	John Thomas Lucas, Jr., Daniel Victor Wakefield, Michael Doubrovin, Yimei Li, Teresa Santiago, Sara Michele Federico, Thomas E. Merchant, Andrew M. Davidoff, Matthew J. Krasin, Barry L. Shulkin, Victor M. Santana, Wayne Lee Furman
Format:	Article
Language:	English
Published:	Elsevier 2022-05-01
Series:	Clinical and Translational Radiation Oncology
Online Access:	http://www.sciencedirect.com/science/article/pii/S240563082200012X

Similar Items

Analysis of quantitative [I-123] mIBG SPECT/CT in a phantom and in patients with neuroblastoma
by: Samuel L. Brady, et al.
Published: (2019-12-01)

Anti-GD2 Directed Immunotherapy for High-Risk and Metastatic Neuroblastoma
by: Godfrey Chi-Fung Chan, et al.
Published: (2022-02-01)

Metastatic Burden Defines Clinically and Biologically Distinct Subgroups of Stage 4 High-Risk Neuroblastoma
by: Eun Seop Seo, et al.
Published: (2020-08-01)

TWIST1 expression is associated with high-risk neuroblastoma and promotes primary and metastatic tumor growth
by: Maria-Vittoria Sepporta, et al.
Published: (2022-01-01)

Bone Marrow Environment in Metastatic Neuroblastoma
by: Chiara Brignole, et al.
Published: (2021-05-01)

Treatment of High-Risk Neuroblastoma
by: Julie Krystal, et al.
Published: (2023-07-01)

Treatment of high-risk neuroblastoma
by: Ki Woong Sung
Published: (2012-04-01)

The Evolution of Risk Classification for Neuroblastoma
by: Elizabeth Sokol, et al.
Published: (2019-02-01)

Metastatic congenital neuroblastoma associated with in situ neuroblastoma: case report and review of literature
by: Andressa Dias Costa, et al.
Published: (2014-06-01)

Akt2 regulates metastatic potential in neuroblastoma.
by: Jingbo Qiao, et al.
Published: (2013-01-01)

The genetic landscape of high-risk neuroblastoma
by: Lander, Eric Steven
Published: (2014)

Risk-directed therapy and research in neuroblastoma
by: Yen-Lin Liu, et al.
Published: (2014-12-01)

High-Risk Neuroblastoma Treatment Review
by: Valeria Smith, et al.
Published: (2018-08-01)

Treatment of High-Risk Neuroblastoma with Dinutuximab and Chemotherapy Administered in all Cycles of Induction
by: Margaret Cupit-Link, et al.
Published: (2023-09-01)

Comprehensive molecular profiling of advanced/metastatic olfactory neuroblastomas.
by: Jasmina Topcagic, et al.
Published: (2018-01-01)

High-Risk Neuroblastoma: A Surgical Perspective
by: Jillian C. Jacobson, et al.
Published: (2023-02-01)

Intermediate risk neuroblastoma: Is surgery really an endpoint?
by: Prashant Prabhakar, et al.
Published: (2022-01-01)

Novel drug - dinutuximab for high-risk neuroblastoma
by: Supriya Kushwah, et al.
Published: (2018-01-01)

Integrative discovery of treatments for high-risk neuroblastoma
by: Elin Almstedt, et al.
Published: (2020-01-01)

MYCN amplification plus 1p36 loss of heterozygosity predicts ultra high risk in bone marrow metastatic neuroblastoma
by: Zhi‐Xia Yue, et al.
Published: (2022-04-01)

Abdominal compartment syndrome secondary to sepsis and metastatic neuroblastoma in an infant
by: Sara Batalha, et al.
Published: (2015-01-01)

CONGENITAL NEUROBLASTOMA: A RARE CASE OF PLURIVISCERAL METASTATIC DISSEMINATION
by: Antonina Argo
Published: (2021-07-01)

Identification of the molecular subtypes and construction of risk models in neuroblastoma
by: Enyang He, et al.
Published: (2023-07-01)

The significance of metaiodobenzylguanidine scintigraphy in the treatment of high risk neuroblastomas
by: Nikolić Katarina, et al.
Published: (2020-01-01)

Anti-tumor effects of rigosertib in high-risk neuroblastoma
by: Katarzyna Radke, et al.
Published: (2021-08-01)

Distinct signatures of the immune responses in low risk versus high risk neuroblastoma
by: Wang Ena, et al.
Published: (2011-10-01)

Radiological and pathological findings of a metastatic composite paraganglioma with neuroblastoma in a man: a case report
by: Koch Sonja, et al.
Published: (2010-11-01)

Immunogenomic determinants of tumor microenvironment correlate with superior survival in high-risk neuroblastoma
by: Bao, Riyue, et al.
Published: (2023)

Feature Genes in Neuroblastoma Distinguishing High-Risk and Non-high-Risk Neuroblastoma Patients: Development and Validation Combining Random Forest With Artificial Neural Network
by: Sha Yang, et al.
Published: (2022-07-01)

Glycation Leads to Increased Polysialylation and Promotes the Metastatic Potential of Neuroblastoma Cells
by: Maximilian Scheer, et al.
Published: (2020-04-01)

[123I]-metaiodobenzylguanidine imaging findings and outcome in patients with metastatic neuroblastoma
by: Yaw A. Amoako, et al.
Published: (2023-03-01)

Paired tumor and normal whole genome sequencing of metastatic olfactory neuroblastoma.
by: Glen J Weiss, et al.
Published: (2012-01-01)

Improved risk stratification by PET-based intratumor heterogeneity in children with high-risk neuroblastoma
by: Chao Li, et al.
Published: (2022-10-01)

Hemorrhage During Induction Chemotherapy in Neuroblastoma: Additional Risk Factors in High-Risk Patients
by: Valerio Voglino, et al.
Published: (2021-11-01)

Prognostic factors for intermediate- or high-risk neuroblastomas in children in China
by: Yi Zhang, et al.
Published: (2023-12-01)

RTEL1 gene polymorphisms and neuroblastoma risk in Chinese children
by: Ting Zhang, et al.
Published: (2023-11-01)

Computational Identification of Gene Networks as a Biomarker of Neuroblastoma Risk
by: Lidan Sun, et al.
Published: (2020-07-01)

Intra-Tumour Genetic Heterogeneity and Prognosis in High-Risk Neuroblastoma
by: Amparo López-Carrasco, et al.
Published: (2021-10-01)

Early Use of Dinutuximab Beta in Patients with High-Risk Neuroblastoma
by: Neofit Spasov, et al.
Published: (2021-01-01)

Clinically Relevant Biomarker Discovery in High-Risk Recurrent Neuroblastoma
by: Peter Utnes, et al.
Published: (2019-03-01)